Diabetic retinopathy (DR) is typically asymptomatic in its early stages. Therefore, best practice guidelines recommend people with diabetes have annual eye exams to screen for DR, nonproliferative DR, and diabetic macular edema to allow for early detection and timely treatment.
This series of regional, interactive, virtual symposia hosted by retina specialists is designed to foster collaboration in provider networks and encourage discussions on the latest trial data and clinical experience related to the importance of imaging and how early treatment can preserve vision in patients with diabetes. Other topics of discussion will include how practices have adapted as a result of the COVID-19 pandemic; the benefits of telemedicine; longer-duration therapies that require fewer visits to the clinic; and ways to improve communication with interdisciplinary care providers.
This certified CE educational activity is designed for optometrists involved in the management of patients with diabetic eye diseases.
Supported by an unrestricted educational grant from Regeneron Pharmaceuticals.
